Global /Australia /Healthcare /Biotechnology /CVB
chevron_leftBack
CurveBeam AI Ltd. logo

CurveBeam AI Ltd.

CVB
ASX: CVB Delayed
0.0600AUD 1.7%
0.0423 USD
As of 14 June 2026, CurveBeam AI Ltd. has a market cap of $20.15M USD, ranking #37022 globally and #1066 in Australia. It ranks #3320 in the Healthcare sector, and #647 in the Biotechnology industry.
Global Rank
37022
Country Rank
1066
Sector Rank
3320
Industry Rank
647
Key Stats
Market Cap
$20.15MUSD
28.66M AUD
Enterprise Value
$29.45MUSD
41.8M AUD
Revenue (TTM)
$8.54MUSD
12.15M AUD
EBITDA (TTM)
-$8.46MUSD
-12.01M AUD
Net Income (TTM)
-$11.36MUSD
-16.17M AUD
EBITDA Margin
-99%
Profit Margin
-133%
PS Ratio
2.4
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Gregory Brown open_in_new
Employees
50
Founded
2009
Website
curvebeamai.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.7% -11% 16% -25% -28% -41%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
CVB
CurveBeam AI Ltd
ISIN: AU0000289761
Shares Out.:
477.734M1 Shares Float: 339.171M2
TV:
SA:
YF:
GF:
BA:
CVB
MS:
0.0600 AUD
OTC Markets
MIC: OTCM
CRVAF
CurveBeam AI Ltd
ISIN: AU0000289761
Shares Out.:
390.273M1 Shares Float: 277.078M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0540 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About CurveBeam AI Ltd.

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

Similar Companies

Industry: Biotechnology (Australia)
Name
Market Cap diff.
PE
CSL
$42.36B
60.27B AUD
210K%
29.3
$3.58B
5.09B AUD
18K%
-
MSB
$2.02B
2.88B AUD
10K%
-
PNV
$490.46M
697.75M AUD
2K%
71.8
$141.64M
603%
-
IMM
$65.26M
92.84M AUD
224%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
905K%
23.9
GILD
$159.92B
794K%
19.0
ARGX
$47.84B
41.39B EUR
237K%
39.9
$44.84B
68.19T KRW
222K%
35.5
LONN
$42.3B
33.71B CHF
210K%
37.2
068270
$28.11B
42.76T KRW
139K%
43.8
chevron_leftBack